| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.08 |